Best Stocks Under $20 To Buy In 2023
paymentsDiscover value opportunities among Stocklytics' Best Stocks Under $20 to Buy in 2023, offering affordable stocks with potential for growth. These picks combine affordability with potential for appreciation, catering to investors seeking options under $20 per share. Stocklytics focuses on undervalued stocks trading below $20, indicating potential for upward movement. Whether you're looking for bargain opportunities or aiming to diversify your portfolio, Stocklytics' selections offer a diverse range of stocks positioned for potential appreciation in the coming year.
| name | Price | $ Change | % Change | Market Cap | Score language | Tags | Volume | Avg. Volume | Technicals | Dividend Y | ROI 1Y | Last 7 Days | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 PATHUiPath | $12.44 | $0.14 | arrow_drop_up1.13% | $6.99B | High Quality | 6.38M | 12.38 | Neutralremove | - | -36.47% | |||||
ASURAsure Software | $9.33 | -$0.11 | arrow_drop_down1.21% | $271.54M | High Growth | 18.19K | 9.37 | Neutralremove | - | 24.13% | |||||
MGMistras Group | $7.37 | -$0.01 | arrow_drop_down0.13% | $252.83M | High Growth | 82.98K | 7.33 | Neutralremove | - | -16.03% | |||||
SOPASociety Pass Incorporated Common Stock | $1.36 | $0.12 | arrow_drop_up9.37% | $5.71M | High Growth | 190.88K | 1.32 | Neutralremove | - | -25.59% | |||||
IASIntegral Ad Science Holding | $7.84 | -$0.15 | arrow_drop_down1.93% | $1.32B | - | 997.37K | 7.84 | Neutralremove | - | -20.11% | |||||
CRDFCardiff Oncology | $3.01 | $0.15 | arrow_drop_up5.20% | $182.94M | Penny Stock | 1.15M | 3.02 | Neutralremove | - | -12.86% | |||||
ESOAEnergy Services of America | $10.65 | $0.49 | arrow_drop_up4.88% | $142.60M | - | 276.53K | 10.51 | Neutralremove | 1.12% | 71.30% | |||||
WVEWaVe Life Sciences Ltd | $5.90 | -$0.15 | arrow_drop_down2.46% | $971.04M | - | 532.50K | 5.99 | Neutralremove | - | -8.30% | |||||
AALAmerican Airlines Group | $11.18 | -$0.20 | arrow_drop_down1.75% | $7.75B | - | 38.37M | 11.16 | Neutralremove | - | -20.67% | |||||
INTZIntrusion | $1.48 | -$0.05 | arrow_drop_down3.26% | $31.63M | High Growth | 285.79K | 1.48 | Neutralremove | - | -9.01% | |||||
VTVTvTv Therapeutics | $18.21 | -$1.24 | arrow_drop_down6.37% | $58.65M | High Growth | 3.47K | 18.99 | Neutralremove | - | -37.22% | |||||
BZKanzhun Limited | $17.45 | $0.19 | arrow_drop_up1.10% | $7.98B | - | 940.62K | 17.42 | Neutralremove | - | -21.93% | |||||
MGNIMagnite | $15.35 | -$0.18 | arrow_drop_down1.15% | $2.24B | High Growth | 750.07K | 15.39 | Neutralremove | - | 34.31% | |||||
GSATGlobalstar | $18.23 | -$0.28 | arrow_drop_down1.51% | $2.36B | High Growth | 289.99K | 18.19 | Neutralremove | - | 6.63% | |||||
HLHecla Mining Co | $5.09 | $0.07 | arrow_drop_up1.56% | $3.05B | - | 10.32M | 5.08 | Neutralremove | 0.29% | -14.36% | |||||
ADVMAdverum Biotechnologies | $2.16 | -$0.08 | arrow_drop_down3.81% | $42.82M | Penny Stock | 156.61K | 2.17 | Neutralremove | - | -72.58% | |||||
BWMXBetterware de Mexico SAPI de CV | $8.85 | -$0.21 | arrow_drop_down2.28% | $349.65M | High Dividend | 49.49K | 9.05 | Neutralremove | - | -47.44% | |||||
ARCTArcturus Therapeutics Holdings | $12.04 | -$0.67 | arrow_drop_down5.23% | $315.68M | - | 254.27K | 12.23 | Neutralremove | - | -62.80% | |||||
URGNUroGen Pharma Ltd | $4.04 | -$0.05 | arrow_drop_down1.22% | $454.15M | - | 1.63M | 3.96 | Neutralremove | - | -69.61% | |||||
SAGESage Therapeutics | $6.53 | -$0.09 | arrow_drop_down1.36% | $413.92M | - | 456.14K | 6.53 | Neutralremove | - | -46.00% |
Showing 161-180 of 742
Results per page:
About Best Stocks Under $20 To Buy In 2023
Discover value opportunities among Stocklytics' Best Stocks Under $20 to Buy in 2023, offering affordable stocks with potential for growth. These picks combine affordability with potential for appreciation, catering to investors seeking options under $20 per share. Stocklytics focuses on undervalued stocks trading below $20, indicating potential for upward movement. Whether you're looking for bargain opportunities or aiming to diversify your portfolio, Stocklytics' selections offer a diverse range of stocks positioned for potential appreciation in the coming year.
Discover the Power of Stocklytics Tools
Our suite of tools empowers you to make informed decisions, seize opportunities, and stay ahead in the competitive trading world.
See Stocklytics Tools